My research interests include antimicrobial susceptibility testing and evaluating
new therapeutic agents for nontuberculous mycobacterial (NTM) infections. I am interested
in collaborating with pharmaceutical companies to support the development and evaluation
of novel treatments that improve patient outcomes, enhance treatment options, and
ultimately improve quality of life for individuals affected by NTM disease.